Brief: Uniqure - Strategic Reorganization To Focus On Advancing Multiple Clinical-Stage Programs, Sees $180 Million Of Cost Savings Over Next 3 Years
07/11/2023 12:21
Nov 7 (Reuters) - Uniqure NV UQ1.F :
* UNIQURE NV - STRATEGIC REORGANIZATION TO FOCUS ON
ADVANCING
MULTIPLE CLINICAL-STAGE PROGRAMS, SEES $180 MILLION OF COST
SAVINGS OVER NEXT 3 YEARS
* UNIQURE NV - STRONG CASH POSITION OF ABOUT $660 MILLION AS
OF
SEPTEMBER 30, 2023 EXPECTED TO FUND OPERATIONS INTO Q2 OF 2027
Source text for Eikon: ID:nGNE5wn6lv
Further company coverage: UQ1.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on uniQure
See all newsuniQure tumbles after updated Huntington's disease gene therapy data
UniQure plunges as Huntington's trial data disappoints investors (updated)
uniQure tumbles after updated Huntington's disease gene therapy data
UniQure's Huntington's therapy fails to significantly slow disease progression in trial
uniQure seeks US approval for Huntington's gene therapy after FDA reversal